These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26693960)

  • 1. Phenibut (4-amino-3-phenyl-butyric acid): Availability, prevalence of use, desired effects and acute toxicity.
    Owen DR; Wood DM; Archer JR; Dargan PI
    Drug Alcohol Rev; 2016 Sep; 35(5):591-6. PubMed ID: 26693960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the availability, prevalence of use, desired effects, acute toxicity and dependence potential of the novel opioid MT-45.
    Siddiqi S; Verney C; Dargan P; Wood DM
    Clin Toxicol (Phila); 2015 Jan; 53(1):54-9. PubMed ID: 25430506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of phenibut withdrawal focusing on complications, therapeutic approaches, and single substance versus polysubstance withdrawal.
    Feldman R; Autry B; Dukes J; Lofy T; Marchetti G; Patt A; Batterman N; Theobald J
    Clin Toxicol (Phila); 2023 Nov; 61(11):941-951. PubMed ID: 38112312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenibut (β-Phenyl-γ-Aminobutyric Acid): an Easily Obtainable "Dietary Supplement" With Propensities for Physical Dependence and Addiction.
    Jouney EA
    Curr Psychiatry Rep; 2019 Mar; 21(4):23. PubMed ID: 30852710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4'-DMAR, 4,4'-dimethylaminorex): availability, prevalence of use, desired effects and acute toxicity.
    Glanville J; Dargan PI; Wood DM
    Hum Psychopharmacol; 2015 May; 30(3):193-8. PubMed ID: 25784180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenibut: A drug with one too many "buts".
    Gurley BJ; Koturbash I
    Basic Clin Pharmacol Toxicol; 2024 Oct; 135(4):409-416. PubMed ID: 39197876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenibut dependence.
    Samokhvalov AV; Paton-Gay CL; Balchand K; Rehm J
    BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23391959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethylphenidate: availability, patterns of use, and acute effects of this novel psychoactive substance.
    Ho JH; Bailey GP; Archer JR; Dargan PI; Wood DM
    Eur J Clin Pharmacol; 2015 Oct; 71(10):1185-96. PubMed ID: 26195274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenibut Addiction in a Patient with Substance Use Disorder.
    Zheng KH; Khan A; Espiridion ED
    Cureus; 2019 Jul; 11(7):e5230. PubMed ID: 31565631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute behavioural disturbance associated with phenibut purchased via an internet supplier.
    Downes MA; Berling IL; Mostafa A; Grice J; Roberts MS; Isbister GK
    Clin Toxicol (Phila); 2015; 53(7):636-8. PubMed ID: 26114346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sedative-Hypnotic Agents That Impact Gamma-Aminobutyric Acid Receptors: Focus on Flunitrazepam, Gamma-Hydroxybutyric Acid, Phenibut, and Selank.
    Doyno CR; White CM
    J Clin Pharmacol; 2021 Aug; 61 Suppl 2():S114-S128. PubMed ID: 34396551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using internet snapshot surveys to enhance our understanding of the availability of the novel psychoactive substance 4-methylaminorex and 4,4'-dimethylaminorex.
    Nizar H; Dargan PI; Wood DM
    J Med Toxicol; 2015 Mar; 11(1):80-4. PubMed ID: 25167967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxidrome of an Easily Obtainable Nootropic: A Case Report of Phenibut Intoxication and Withdrawal Delirium.
    Martin R; Buffenstein I; Cho D; Kiyokawa M
    J Clin Psychopharmacol; 2023 Nov-Dec 01; 43(6):507-510. PubMed ID: 37930202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Phenibut Use Disorder and Withdrawal in a Geriatric Patient.
    Wainblat E; Weleff J; Anand A
    Am J Geriatr Psychiatry; 2023 Jan; 31(1):67-74. PubMed ID: 36266201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenibut: Review and Pharmacologic Approaches to Treating Withdrawal.
    Penzak SR; Bulloch M
    J Clin Pharmacol; 2024 Jun; 64(6):652-671. PubMed ID: 38339875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDMB-CHMICA: Availability, Patterns of Use, and Toxicity Associated With This Novel Psychoactive Substance.
    Haden M; Archer JR; Dargan PI; Wood DM
    Subst Use Misuse; 2017 Jan; 52(2):223-232. PubMed ID: 27759479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Tolerability of the Anxiolytic and Nootropic Drug Phenibut: A Systematic Review of Clinical Trials and Case Reports.
    Kupats E; Vrublevska J; Zvejniece B; Vavers E; Stelfa G; Zvejniece L; Dambrova M
    Pharmacopsychiatry; 2020 Sep; 53(5):201-208. PubMed ID: 32340063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacological activity of optical isomers of phenibut.
    Dambrova M; Zvejniece L; Liepinsh E; Cirule H; Zharkova O; Veinberg G; Kalvinsh I
    Eur J Pharmacol; 2008 Mar; 583(1):128-34. PubMed ID: 18275958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenibutan-an Illegal Food Supplement With Psychotropic Effects and Health Risks.
    Bonnet U; Scherbaum N; Schaper A; Soyka M
    Dtsch Arztebl Int; 2024 Apr; 121(7):222-227. PubMed ID: 38377332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of phenibut in France: report of two cases].
    Schmitt C; Gégu C; Spadari M; de Haro L
    Therapie; 2013; 68(2):123-4. PubMed ID: 23773355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.